The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha) has earned conditional approval by the European Medicines Agency. Click or tap here for details.
Posts - Anticoagulant Therapy
Mar 6, 2019 7:54am
0 Comments
Feb 20, 2019 7:16pm
On February 15, Heart.org reviewed the outcomes of a study published in the New England Journal documenting the clinical efficacy of andexanet alfa (Andexxa).
0 Comments
Feb 18, 2019 11:31am
A subscriber asks, I just received this week a cortisone shot in my knee. I am and have been on Warfarin for many years. Since the shot I seem to be dizzy and
light headed. Is this common?
0 Comments
Feb 2, 2019 8:05pm
Here's a January 31, 2019 Medscape article describing updated guidelines for using DOACs in non-valvular atrial fibrillation.
0 Comments
